Trade Report: The Hays Advisory LLC Reached $5,152,000 position of UnitedHealth Group Inc. (UNH)

The Hays Advisory LLC Reached $5,152,000 position  of UnitedHealth Group Inc. (UNH)

Hays Advisory LLC reduced its position in UnitedHealth Group Inc. (NYSE:UNH) by 9.4% during the third quarter, Holdings Channel reports. The fund owned 36,797 shares of the healthcare conglomerate’s stock after selling 3,800 shares during the period. UnitedHealth Group comprises approximately 0.9% of Hays Advisory LLC’s holdings, making the stock its 29th largest position. Hays Advisory LLC’s holdings in UnitedHealth Group were worth $5,152,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the company. Boothbay Fund Management LLC bought a new stake in UnitedHealth Group during the first quarter worth about $286,000. Fulton Bank N.A. increased its stake in UnitedHealth Group by 21.9% in the second quarter. Fulton Bank N.A. now owns 7,005 shares of the healthcare conglomerate’s stock worth $989,000 after buying an additional 1,259 shares during the last quarter. Kistler Tiffany Companies LLC increased its stake in UnitedHealth Group by 4.3% in the second quarter. Kistler Tiffany Companies LLC now owns 3,617 shares of the healthcare conglomerate’s stock worth $511,000 after buying an additional 149 shares during the last quarter. First Financial Bank N.A. Trust Division increased its stake in UnitedHealth Group by 0.3% in the second quarter. First Financial Bank N.A. Trust Division now owns 7,847 shares of the healthcare conglomerate’s stock worth $1,108,000 after buying an additional 21 shares during the last quarter. Finally, Cullinan Associates Inc. increased its stake in UnitedHealth Group by 9.2% in the second quarter. Cullinan Associates Inc. now owns 29,967 shares of the healthcare conglomerate’s stock worth $4,231,000 after buying an additional 2,517 shares during the last quarter. Institutional investors own 86.04% of the company’s stock.

Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.48% during trading on Friday, hitting $152.81. 1,664,542 shares of the company’s stock were exchanged. The stock has a market cap of $145.45 billion, a PE ratio of 22.57 and a beta of 0.63. The stock’s 50-day moving average price is $143.37 and its 200-day moving average price is $139.61. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $154.50.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The firm had revenue of $46.30 billion for the quarter, compared to the consensus estimate of $46.09 billion. During the same period in the previous year, the company earned $1.77 earnings per share. The company’s quarterly revenue was up 11.6% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Inc. will post $8.01 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Friday, December 2nd will be issued a $0.625 dividend. The ex-dividend date of this dividend is Wednesday, November 30th. This represents a $2.50 annualized dividend and a dividend yield of 1.64%. UnitedHealth Group’s dividend payout ratio is currently 36.93%.

UNH has been the topic of a number of recent research reports. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a report on Sunday, August 21st. Jefferies Group restated a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, August 23rd. Sanford C. Bernstein restated an “outperform” rating and set a $178.00 price target on shares of UnitedHealth Group in a report on Tuesday, September 6th. Cowen and Company set a $150.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Tuesday, September 6th. Finally, Evercore ISI initiated coverage on shares of UnitedHealth Group in a report on Thursday, September 22nd. They set a “buy” rating and a $155.00 price target on the stock. Two analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $158.03.

In related news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at $271,100,350.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP D Ellen Wilson sold 14,365 shares of the company’s stock in a transaction dated Friday, October 21st. The shares were sold at an average price of $144.18, for a total transaction of $2,071,145.70. Following the completion of the transaction, the executive vice president now owns 66,635 shares in the company, valued at $9,607,434.30. The disclosure for this sale can be found here. 1.65% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Related posts

Leave a Comment